Jacob George
The University of Sydney · 520 works · 40,235 citations · h-index 78
Top works
- The NAFLD fibrosis score
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
- NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome
- MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease
- Long–Term Outcomes of Cirrhosis in Nonalcoholic Steatohepatitis Compared With Hepatitis C
- Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
- Insulin resistance is associated with chronic hepatitis C and virus infection fibrosis progression
- Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates
- Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study
- Hepascore: An Accurate Validated Predictor of Liver Fibrosis in Chronic Hepatitis C Infection
- The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
- Hepatitis C virus genotype 3 is cytopathic to hepatocytes: Reversal of hepatic steatosis after sustained therapeutic response
- Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis
- Advancing the global public health agenda for NAFLD: a consensus statement
- HFE mutations, hepatic iron, and fibrosis: Ethnic-specific association of NASH with C282Y but not with fibrotic severity
- Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: A manifestation of lipotoxicity?
- Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease
- Which patients with hepatitis C develop liver complications?
- Obesity Is a Risk Factor for Greater COVID-19 Severity
- Non‐alcoholic steatohepatitis in the Asia–Pacific region: Future shock?